LIGAND PHARMACEUTICALS INCORPORATED Operating Lease Liability
LIGAND PHARMACEUTICALS INCORPORATED (LGNZZ) had Operating Lease Liability of $5.30 million as of 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-02-27
- 2025-12-31: Operating Lease, Liability $5.30M.
- 2024-12-31: Operating Lease, Liability $7.08M.
- 2023-12-31: Operating Lease, Liability $6.16M.
- 2022-12-31: Operating Lease, Liability $11.01M.
| Period end | Operating Lease, Liability |
|---|---|
| 2025-12-31 | $5.30M 10-K · filed 2026-02-27 |
| 2024-12-31 | $7.08M 10-K · filed 2025-02-28 |
| 2023-12-31 | $6.16M 10-K · filed 2024-02-29 |
| 2022-12-31 | $11.01M 10-K · filed 2023-02-28 |
| 2022-09-30 | $37.24M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $29.59M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $18.70M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $17.55M 10-K · filed 2022-02-28 |
| 2021-09-30 | $13.65M 10-Q · filed 2021-11-09 |
| 2020-12-31 | $7.53M 10-K · filed 2021-02-24 |
| 2019-12-31 | $11.21M 10-K · filed 2020-02-27 |
| 2019-09-30 | $10.86M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $11.48M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $5.51M 10-Q · filed 2019-05-09 |